Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?
The European Medicines Agency (EMA) reports that AAHS was introduced without any prelicensure safety evaluation.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
